Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis
This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc.
Authors
- Xu Guo
- Siyue Chen (ORCID: https://orcid.org/0009-0009-9234-0689)
- Yanfang Peipei Zhu (ORCID: https://orcid.org/0000-0001-6908-0860)
- Mei Du (ORCID: https://orcid.org/0000-0001-7792-1156)
- Hua Yan (ORCID: https://orcid.org/0000-0002-7651-840X)
- Qiang Liu (ORCID: https://orcid.org/0000-0001-5811-1289)
- Lei Yi (ORCID: https://orcid.org/0000-0001-6388-0074)
- Yuming Liu (ORCID: https://orcid.org/0000-0002-9857-5018)
- Kai He (ORCID: https://orcid.org/0000-0002-1180-9951)
- Xiaohong Wang (ORCID: https://orcid.org/0000-0001-8925-5736)
- Yutian Zhang
- Tinghui Bai
Institutions
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1111/bph.17344
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City
- National Key Research and Development Program of China